Hemex Health

05/18/2026

We were honored to see Hemex Health and the Gazelle® platform* featured in this Kenyan national news segment as part of an important initiative expanding access to sickle cell screening and care in Kenya.

On April 29, Hemex Health’s Gazelle® platform was featured during a newborn screening training initiative in the Kisumu and Nyanza regions of Kenya, with the goal of expanding access to sickle cell disease diagnostics and care.

The event brought together nurses, community health workers, and representatives from Kenya’s Ministry of Health (MOH), including Dr. Yvet Kisaka; Selina Olwanda, CEO of the Children’s Sickle Cell Foundation; Mr. Abdou Salam of Fondation Pierre Fabre; and Emily Gumbo, CEO of the Sickle Cell Federation of Kenya, to strengthen diagnostic capacity at Level 3 and 4 county hospitals.

As part of an ongoing collaboration with the MOH and AMPATH Kenya, Gazelle has been incorporated into the Afya Dhabiti program to support screening efforts for 2,000 infants ages 0–5 in Migori, Siaya, and Trans-Nzoia counties, while also supporting hydroxyurea monitoring and long-term disease management through stakeholder engagement and collaboration.



*Product not for sale in the US

05/15/2026

This International Day of Families, Hemex Health recognizes the important connection between early diagnosis, access to care, and family wellbeing.

This year’s theme, “Families, Inequalities and Child Wellbeing,” highlights how access to healthcare and early intervention can shape a child’s future and support stronger, healthier families worldwide.

The World Health Organization (WHO) recognizes early detection and comprehensive care as critical to reducing complications and improving survival for children living with sickle cell disease.

At Hemex Health, we are committed to expanding access to timely, diagnostic tools that help bring screening and care closer to the communities that need it most.

Learn more:
WHO – Sickle Cell Disease: https://www.who.int/health-topics/sickle-cell-disease
United Nations – International Day of Families: https://www.un.org/en/observances/families-day

05/14/2026

It was incredibly valuable to attend the American Society for Apheresis (ASFA) meeting and see how red blood cell exchange is advancing care for patients with sickle cell disease — and how important timely hemoglobin data can be in supporting these workflows.

Shown here is Jack Fischer, Global Product Manager at Hemex Health, with Dr. John Manis at Boston Children’s Hospital, who is currently working to better understand how red blood cell exchange (RBCx) can be made more efficient and personalized for each sickle cell patient.

Gazelle Products not for sale in the US*

05/10/2026

This International Thalassaemia Day, Hemex Health joins the global call to make thalassaemia by expanding access to timely, accurate diagnostic insights that help clinicians make informed treatment decisions and improve patient care worldwide.





Hemex Health products not for sale in the US*

04/29/2026

04/29/2026

What a wonderful day! Stakeholders engagement and training of HCP in Kisumu county by Children Sickle Cell Foundation under the guidance of Selina Olwanda Ogweno and Dr. Yvette Kisaka of the MOH.

Thank you Haroun Ayub, Bsc. MLS from Keton Consulting Limited for a fantastic job done with the Hb electrophoresis
Sickle Cell Federation of Kenya
. Hemex Health, Inc. “ we keep impacting society”

04/07/2026

Hemex Health is proud to support the launch of the campaign ahead of featuring real stories from patients, caregivers, advocates & professionals—because every perspective matters.

brings these voices together in one interactive platform, offering a 360- degree look at how sickle cell disease affects lives across the world and how the disease progresses and evolves over time. Through stories, expert interviews, and personal reflections, the campaign showcases the resilience of the sickle cell community and the collective strength driving progress.

Start exploring at: sicklecell360.info

03/19/2026

At the 1st National Day of Pooling of Hyperspecialty Resources(1ère Journée Nationale des Mutualisations des hyperspecialités) in DR Congo, with over 250 delegates in attendance. It was all about resource mobilisation in addressing in Congo. A bold step in combatting neglected disease areas of concerns within most vanorable populace in our societies.

drives both , and diagnostic interventions that speaks to the hearts and minds of healthcare professionals addressing challenges faced within a disenfranchised and care settings. The importance of early diagnosis of anemia, continuous monitoring of deficiency as well as early diagnosis of is the cornerstone of electrophoresis by Hemex Health, Inc. In both urban and rural setting, speaking to right to quality healthcare for all. Thanks to our partners in DRC for engaging stakeholders on such important solutions to market.

03/12/2026

To effectively address challenges of and it’s impact in the society in Africa. There has to be collective responsibility and effective political good will. This will ensure placing disease burned at the right level of action as well as effective resources Mobility.

Congratulations to MoH Uganda- Department of National Health Laboratory and Diagnostic Services(NHLDS) Parliament of Uganda for taking the first step forward in the continent. I thank our partner NICOSAM HEALTHCARE LTD and other stakeholders who have put their skin in the game.
We continue to advance critical provision of care in diagnostic using HB electrophoresis an innovative technology from Hemex Health, Inc.
Terumo Blood and Cell Technologies David Obluk Gerrit J. van Roekel Patti White

03/08/2026

This International Women’s Day, the theme reminds us that when we invest in women, everyone benefits. By providing support, opportunity, and access, we build stronger communities, healthier families, and more resilient health systems.

Today, we celebrate the women advancing healthcare — delivering care, driving research, leading innovation, and championing better outcomes around the world.